A vocal critic of the Trump administration’s policies at the National Institutes of Health (NIH) has been placed on administrative leave, raising concerns about the implications for scientific integrity and freedom of expression within federal agencies. Jenna Norton, a program official at the National Institute of Diabetes and Digestive and Kidney Diseases, received notification of her immediate leave with full pay, but the email did not specify the reasons behind this decision.
This abrupt action has sparked discussions among B2B professionals in the pharmaceutical sector regarding the potential chilling effects on researchers who may wish to voice dissent or critique governmental policies. The NIH’s handling of this situation could influence the agency’s reputation and its ability to attract and retain talent, particularly among those who prioritize scientific independence and transparency in their work.
Start your 7-day trial and see what the database can do →
